Grant T. Corbett, PhD - Publications

2005-2009 Psychology University of North Dakota, Grand Forks, ND, United States 
 2010-2015 Neurological Sciences Rush University Medical Center, Chicago, IL, United States 
 2015- Neurologic Diseases Harvard Medical School - Brigham and Women's Hospital 
AD alpha-secretases

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Corbett GT, Buss EW. Non-neuronal cells exacerbate β-amyloid aggregation in the aged brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 9825-7. PMID 25057186 DOI: 10.1523/JNEUROSCI.1825-14.2014  0.64
2013 Roy A, Jana M, Corbett GT, Ramaswamy S, Kordower JH, Gonzalez FJ, Pahan K. Regulation of cyclic AMP response element binding and hippocampal plasticity-related genes by peroxisome proliferator-activated receptor α. Cell Reports. 4: 724-37. PMID 23972989 DOI: 10.1016/j.celrep.2013.07.028  0.64
2013 Li X, Kroin JS, Kc R, Gibson G, Chen D, Corbett GT, Pahan K, Fayyaz S, Kim JS, van Wijnen AJ, Suh J, Kim SG, Im HJ. Altered spinal microRNA-146a and the microRNA-183 cluster contribute to osteoarthritic pain in knee joints. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 28: 2512-22. PMID 23744481 DOI: 10.1002/jbmr.2002  0.64
2013 Corbett GT, Roy A, Pahan K. Sodium phenylbutyrate enhances astrocytic neurotrophin synthesis via protein kinase C (PKC)-mediated activation of cAMP-response element-binding protein (CREB): implications for Alzheimer disease therapy. The Journal of Biological Chemistry. 288: 8299-312. PMID 23404502 DOI: 10.1074/jbc.M112.426536  0.64
2012 Ghosh A, Corbett GT, Gonzalez FJ, Pahan K. Gemfibrozil and fenofibrate, Food and Drug Administration-approved lipid-lowering drugs, up-regulate tripeptidyl-peptidase 1 in brain cells via peroxisome proliferator-activated receptor α: implications for late infantile Batten disease therapy. The Journal of Biological Chemistry. 287: 38922-35. PMID 22989886 DOI: 10.1074/jbc.M112.365148  0.64
2012 Corbett GT, Roy A, Pahan K. Gemfibrozil, a lipid-lowering drug, upregulates IL-1 receptor antagonist in mouse cortical neurons: implications for neuronal self-defense. Journal of Immunology (Baltimore, Md. : 1950). 189: 1002-13. PMID 22706077 DOI: 10.4049/jimmunol.1102624  0.64
Show low-probability matches.